With reference to earlier announcement dated July 30, 2012 regarding Board Meeting on August 10, 2012 to consider and take on record the un-audited financial results of the Company for the first quarter ended June 30, 2012, Sun Pharmaceutical Industries Ltd has now informed BSE that Board meeting to be held on August 10, 2012 to consider the quarterly unaudited results of the Company inter-alia, the following additional agenda items also would be considered : (i) To consider the internal restructuring of the business of the Company with effect from March 31,2012. (ii) To consider declaration of the interim dividend of Rs.4.25 per Share of Re.1 each on Equity Shares of the Company for the year ended March 31, 2012 in lieu of the earlier recommended proposed dividend of Rs.4.25 per Share of Re.1 each on Equity Shares of the Company for the year ended March 31, 2012 in view of the likely delay for the redrawing and audit of the revised accounts for the year ended March 31, 2012 and adoption of accounts by the members due to the proposed restructuring of the business of the Company with effect from March 31,2012, if the Board approves the proposed restructuring.
|